Bristol-Myers Squibb's Cobenfy launch shows strong initial sales and growth potential. Learn why BMY stock is a solid ...

Bristol Myers Squibb BMY announced that it has obtained a positive opinion from the Committee for Medicinal Products for Human Use (“CHMP”) of the European Medicines Agency for two of its drugs.

The efficacy of CD19-CAR T-cell therapy is presumably based on deep tissue depletion of B cells; however, such effect has not been proven in humans in vivo. Methods Sequential ultrasound-guided ...

1Department of Obstetrics and Gynecology, Peking University Third Hospital, China 2Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing, China. 3Biobank, Peking ...

B-cell lymphoma is a type of blood cancer that affects the B lymphocytes of the immune system. They usually arise in the lymph nodes or in other lymphoid tissue, such as the spleen, bone marrow ...

The best hand blenders (or stick blenders) speedily pulverise sauces, soups and smoothies to a consistent texture. We've tested the most popular hand blenders from popular brands – such as Braun, ...

B-cell prolymphocytic leukemia (B-PLL) is a rare, aggressive type of leukemia that progresses rapidly. People with B-PLL typically have a less favorable outlook. However, new targeted treatments ...

Children's Hospital Los Angeles added a 10th cell and gene therapy treatment for children, adolescents and young adults with serious medical conditions. The newest gene therapy treatment ...

They also have other important functions, including cell signaling, viral and bacterial sensing, cell division, cell death, and innate and adaptive immune responses. Consequently, impairment in ...

Qartemi by Immuneel Therapeutics — backed by the Pulitzer-winning cancer physician Dr Siddharth Mukherjee and biotech entrepreneur Kiran Mazumdar Shaw — is the second CAR T-cell therapy to become ...

‘Brain rot’ is increasingly common. Dr. Sanjay Gupta explains how to combat it ...

has made a major breakthrough in treating a common and challenging form of cancer called diffuse large B-cell lymphoma (DLBCL). In a clinical trial known as EPCORE NHL-2, the researchers showed ...